EP 0970054 A1 20000112 - 1-(ISOQUINOLIN-1-YL)-4-(1-PHENYLMETHYL)PIPERAZINES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS
Title (en)
1-(ISOQUINOLIN-1-YL)-4-(1-PHENYLMETHYL)PIPERAZINES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS
Title (de)
1-(ISOCHINOLIN-1-YL)-4-(1-PHENYLMETHYL)-PIPERAZINE; DOPAMIN-REZEPTOR-SUBTYP-SPEZIFISCHE LIGANDEN
Title (fr)
1-(ISOQUINOLINE-1YL)-4-(PHENYLMETHYLE)PIPERAZINES, LIGANDS SPECIFIQUES DU SOUS-TYPE DU RECEPTEUR DE LA DOPAMINE
Publication
Application
Priority
- US 9804051 W 19980303
- US 81072997 A 19970304
Abstract (en)
[origin: WO9839301A1] Disclosed are compounds useful in treating psychotic disorders such as schizophrenia and other central nervous system diseases, where the compounds have general Formula (I), wherein: Ar represents an aryl or heteroaryl group; R1 and R2 independently represent hydrogen, halogen, C1-C6 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, hydroxy, amino, mono- or di(C1-C6)alkyl amino, cyano or trifluoromethyl; and R5 represents hydrogen or C1-C6 alkyl.
IPC 1-7
IPC 8 full level
A61K 31/496 (2006.01); A61P 25/18 (2006.01); C07D 217/22 (2006.01); C07D 405/12 (2006.01)
CPC (source: EP KR)
A61P 25/18 (2017.12 - EP); C07D 217/22 (2013.01 - EP KR); C07D 405/12 (2013.01 - EP)
Citation (search report)
See references of WO 9839301A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9839301 A1 19980911; AU 6678598 A 19980922; CA 2283256 A1 19980911; EP 0970054 A1 20000112; HU 0001391 A2 20001028; HU 0001391 A3 20011228; IL 131427 A0 20010128; JP 2001512491 A 20010821; KR 20000075918 A 20001226; NZ 337183 A 20010525
DOCDB simple family (application)
US 9804051 W 19980303; AU 6678598 A 19980303; CA 2283256 A 19980303; EP 98908854 A 19980303; HU 0001391 A 19980303; IL 13142798 A 19980303; JP 53866498 A 19980303; KR 19997007998 A 19990903; NZ 33718398 A 19980303